email  

Monitoring and Adherence in CML


Imatinib, or Gleevec, is a targeted anti-cancer drug that can keep chronic myelogenous leukemia (CML) in check for most patients for many years. It is important for patients to take imatinib as prescribed by their doctor to fight the disease and to guard against resistance.


You have to upgrade your account to
Insiders Health Membership to watch videos


Sign up now!
Bookmark and Share


Related Stories




Enter your Comment and click the "Submit" Button:


Comments

No Comments Currently